(January 26, 2018, 10:13 AM EST) -- RENO, Nev. — A drug company and its affiliate misappropriated a family’s confidential and trade secret information pertaining to the development of a treatment for a rare genetic disease in violation of state and federal trade secrets law, the family alleges in a Jan. 5 complaint filed in Nevada federal court (Addison Hempel, et al. v. Cydan Development Inc., et al., No. 18-0008, D. Nev.)....